Zur Merkliste hinzufügen
Zurück zur Auswahl

 

45395-01 - Vorlesung: Good Clinical Practice (1 KP)

Semester Herbstsemester 2026
Angebotsmuster Jedes Herbstsemester
Dozierende Eric Huber (eric.huber@unibas.ch, BeurteilerIn)
Elisabeth Anne Reus (elisabeth.reus@unibas.ch)
Meera Saxena (meera.saxena@unibas.ch)
Inhalt Compact two day introductory course to the Good Clinical Practice guideline (GCP) designed according to the requirements of Swissethics.

The course provides a compact insight into the ICH E6 GCP regulation and related topics. It is ideal for Investigators, study personnel and people involved and/or interested in clinical research.

Content:
Principles of the ICH-GCP guideline and its historical background;
Study design and basic statistical principles;
Legal and regulatory requirements of clinical research;
Essential study documentation, incl. structure and content of study protocol;
An overview of how data is processed in clinical trials:
Informed consent and safety aspects;
Quality and data management in clinical trials;
Ethics and submission processes (in Switzerland)
Lernziele Understanding the basic principles of research involving humans
Knowing the fundamental principles of Good Clinical Practice
Literatur Mandatory reading:

Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects Version 2012
https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
-> detailed pre-reading required

Guideline ICH E8(R1) General considerations for clinical studies
https://www.ema.europa.eu/en/ich-e8-general-considerations-clinical-studies-scientific-guideline - detailed pre-reading required

Guideline ICH E6(R3) Good Clinical Practice
https://www.ich.org/page/efficacy-guidelines - familiarizing is of an advantage
Bemerkungen A certificate of participation will be handed out

Film and sound recordings during the course are strictly forbidden (recorders may be confiscated)
Weblink Department of Pharmaceutical Sciences

 

Teilnahmevoraussetzungen Pre-registration by writing an email to studienkoordination-pharma@unibas.ch is mandatory.
Enrolled student at the Department of Pharmaceutical Sciences.
Anmeldung zur Lehrveranstaltung Due to a limited number of seats and the Swissethics certification of the course a pre-registration by writing an email to studienkoordination-pharma@unibas.ch is mandatory.
Unterrichtssprache Englisch
Einsatz digitaler Medien kein spezifischer Einsatz

 

Intervall Wochentag Zeit Raum
täglich Siehe Einzeltermine
Bemerkungen Findet am SwissTPH in Allschwil statt

Einzeltermine

Datum Zeit Raum
Dienstag 19.01.2027 08.45-17.00 Uhr Swiss TPH Neubau, Seminarraum 4
Dienstag 19.01.2027 08.45-17.00 Uhr Swiss TPH Neubau, Seminarraum 5
Mittwoch 20.01.2027 08.45-17.00 Uhr Swiss TPH Neubau, Seminarraum 4
Mittwoch 20.01.2027 08.45-17.00 Uhr Swiss TPH Neubau, Seminarraum 5
Module Modul: Clinical Drug Development: the Basis for Market Approval (Masterstudium: Drug Sciences)
Prüfung Lehrveranst.-begleitend
Hinweise zur Prüfung Complete participation and 70% correct answers in the multiple choice test (self-checking of acquired knowledge) at the end of the seminar
An-/Abmeldung zur Prüfung Anm.: Belegen Lehrveranstaltung; Abm.: stornieren
Wiederholungsprüfung keine Wiederholungsprüfung
Skala Pass / Fail
Belegen bei Nichtbestehen beliebig wiederholbar
Zuständige Fakultät Philosophisch-Naturwissenschaftliche Fakultät, studiendekanat-philnat@unibas.ch
Anbietende Organisationseinheit Departement Pharmazeutische Wissenschaften

Zurück zur Auswahl